Desai MY, Wolski K, Owens A, Naidu SS, et al. Study design and rationale of VALOR-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapy. Am Heart J 2021;239:80-89.
PMID: 34038706